TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21290830

Group type: EXPERIMENTAL
Intervention: Acupuncture (group A)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Electric stimulation (group B)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Conventional therapy (group C)
Number of subjects: 97
Study: 17984504

Group type: EXPERIMENTAL
Intervention: Cortical viscodissection (Group 1)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Non‐viscodissection (Group 2)
Number of subjects: 23
Study: 15860969

Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 123

Group type: COMPARATOR
Intervention: IV nitroglycerin
Number of subjects: 123
Study: 12492610

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (8 mg once a day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 7899525

Group type: EXPERIMENTAL
Intervention: Work rehabilitation program participation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social skills and personal presentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive disorganization and intelligence quotient
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psychopathology levels
Number of subjects: 0
Study: 3028456

Group type: EXPERIMENTAL
Intervention: Enalapril maleate 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frusemide 80 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concomitant use of enalapril and frusemide
Number of subjects: 0
Study: 29768938

Group type: EXPERIMENTAL
Intervention: Ginger extract (400 mg, 5% active ingredient)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 60
Study: 28603411

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 240
Study: 26410011

Group type: EXPERIMENTAL
Intervention: Selective serotonin re‐uptake inhibitor (SSRI)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo medication
Number of subjects: 1000
Study: 22822928

Group type: EXPERIMENTAL
Intervention: Topical application of flurbiprofen (40 mg administered twice at 16 and 2 hours before surgery)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Oral administration of flurbiprofen (40 mg administered twice at 16 and 2 hours before surgery)
Number of subjects: 16
Study: 21534680

Group type: EXPERIMENTAL
Intervention: Social‐cognitive‐emotional (SCE) intervention
Number of subjects: 176

Group type: COMPARATOR
Intervention: Social‐cognitive (SC) intervention
Number of subjects: 176
Study: 19793621

Group type: EXPERIMENTAL
Intervention: Motor cortex stimulation (MCS)
Number of subjects: 5
Study: 16477496

Group type: EXPERIMENTAL
Intervention: C-peptide (6 pmol/kg/min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 8
Study: 15117238

Group type: EXPERIMENTAL
Intervention: 0.2% GTN gel twice a day for a minimum of 6 weeks
Number of subjects: 80
Study: 11284826

Group type: EXPERIMENTAL
Intervention: Continuous infusion of ondansetron
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 80
Study: 9266226

Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (HCG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactate dehydrogenase (LDH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placental alkaline phosphatase (PlAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: At least one of the three markers (HCG, LDH, PlAP)
Number of subjects: 0
Study: 7906128

Group type: EXPERIMENTAL
Intervention: One-on-one educational presentation by a clinical pharmacist, written educational materials, brief follow-up visit, and feedback with recommendations (Group 1)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Face-to-face presentation to departmental groups and the same written educational materials (Group 2)
Number of subjects: 91

Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 91
Study: 3285630

Group type: EXPERIMENTAL
Intervention: Combination of etretinate and PUVA
Number of subjects: 94

Group type: COMPARATOR
Intervention: Etretinate
Number of subjects: 94

Group type: COMPARATOR
Intervention: PUVA
Number of subjects: 94

Group type: COMPARATOR
Intervention: UVB
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 94
Study: 29607842

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin gel
Number of subjects: 20

Group type: COMPARATOR
Intervention: Platelet-rich fibrin membrane
Number of subjects: 20
Study: 27749775

Group type: EXPERIMENTAL
Intervention: Diluted lemon juice before stress imaging and diluted lemon juice with soda water before rest imaging (Group A)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Soda water before stress imaging and diluted lemon juice before rest imaging (Group B)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Combined interventions (Group A)
Number of subjects: 230
Study: 25599738

Group type: EXPERIMENTAL
Intervention: NAC plus routine immunosuppressive regimen (n = 33)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: NAC and vitamin C plus routine regimen (n = 19)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine anti-rejection medication only (n = 32)
Number of subjects: 84
Study: 23295965

Group type: EXPERIMENTAL
Intervention: MEP targeted injections in the psoas muscle
Number of subjects: 7

Group type: COMPARATOR
Intervention: Distal injections in the psoas muscle
Number of subjects: 7
Study: 21075366

Group type: EXPERIMENTAL
Intervention: Adjusted thermal dose based on ovarian volume (60 J/cm³ of ovarian tissue)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Fixed thermal dosage (600 J per ovary)
Number of subjects: 120
Study: 19225955

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) for catatonic schizophrenia
Number of subjects: 53

Group type: COMPARATOR
Intervention: Electroconvulsive therapy (ECT) for non-catatonic schizophrenia
Number of subjects: 53
Study: 17369574

Group type: EXPERIMENTAL
Intervention: Imatinib interrupted (INT)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Imatinib continuous (CONT)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Quality of Life (both INT and CONT)
Number of subjects: 182
Study: 15533104

Group type: EXPERIMENTAL
Intervention: Sacral wedge
Number of subjects: 236

Group type: COMPARATOR
Intervention: Control (no sacral wedge)
Number of subjects: 236
Study: 12018562

Group type: EXPERIMENTAL
Intervention: Long acting nifedipine (nicardia retard 20)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no long acting nifedipine)
Number of subjects: 30
Study: 9041511

Group type: EXPERIMENTAL
Intervention: Low intensity laser irradiation (830nm; 1.5J/cm2)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low intensity laser irradiation (830nm; 9.0J/cm2)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (sham irradiation)
Number of subjects: 48
Study: 7701222

Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Caldwell-Luc (C-L) procedure
Number of subjects: 143
Study: 3606702

Group type: EXPERIMENTAL
Intervention: benzoxonium chloride tablets and gelsolets at doses of 6 mg and 10 mg daily for 4 to 6 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: gargle solutions
Number of subjects: 38
Study: 29275119

Group type: EXPERIMENTAL
Intervention: Momelotinib 200 mg once a day for 24 weeks
Number of subjects: 156

Group type: COMPARATOR
Intervention: Best Available Therapy (BAT)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Momelotinib
Number of subjects: 156

Group type: COMPARATOR
Intervention: BAT
Number of subjects: 156
Study: 27473256

Group type: EXPERIMENTAL
Intervention: Immediately loaded mini-implants after implant placement
Number of subjects: 80

Group type: COMPARATOR
Intervention: Delayed loading of mini-implants after four months (control group)
Number of subjects: 80
Study: 26435245

Group type: EXPERIMENTAL
Intervention: Immediate passive mobilization
Number of subjects: 130

Group type: COMPARATOR
Intervention: Delayed mobilization (immobilization for 4 weeks)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Ultrasonography at 6 weeks
Number of subjects: 130
Study: 24084309

Group type: EXPERIMENTAL
Intervention: Simulation-based practice
Number of subjects: 48

Group type: COMPARATOR
Intervention: Classroom-based practice
Number of subjects: 48
Study: 21339196

Group type: EXPERIMENTAL
Intervention: GnRH antagonist
Number of subjects: 233

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 233
Study: 18381485

Group type: EXPERIMENTAL
Intervention: Use of an automated external defibrillator (AED) followed by calling emergency medical services and performing CPR
Number of subjects: 7001

Group type: COMPARATOR
Intervention: Control response (calling emergency medical services and performing CPR)
Number of subjects: 7001

Group type: EXPERIMENTAL
Intervention: Use of AED
Number of subjects: 7001
Study: 16813849

Group type: EXPERIMENTAL
Intervention: Expectancy of reduced pain (placebo)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Pain information
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Placebo analgesia
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Stress measures (subjective stress, cortisol, circulating beta-endorphin)
Number of subjects: 84
Study: 14652283

Group type: EXPERIMENTAL
Intervention: Serum enterolactone concentration (measured in nmol/liter)
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Increasing quartiles of enterolactone concentration
Number of subjects: 428
Study: 10694112

Group type: EXPERIMENTAL
Intervention: Field based exercise challenge (FBC)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Laboratory based exercise challenge (LBC)
Number of subjects: 23
Study: 8792689

Group type: EXPERIMENTAL
Intervention: Caldwell needle/cannula (CNC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Angiocath needle
Number of subjects: 40
Study: 1619991

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) administration (12 IU/d subcutaneously)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) administration
Number of subjects: 14
Study: 6435664

Group type: EXPERIMENTAL
Intervention: Theophylline 600 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Salbutamol 4 mg
Number of subjects: 12
Study: 31474328

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 18201

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18201
Study: 30382016

Group type: EXPERIMENTAL
Intervention: Adjunctive rifampicin (600-900 mg/day, oral or intravenous) for 14 days
Number of subjects: 758

Group type: COMPARATOR
Intervention: Placebo for 14 days
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: Adjunctive rifampicin
Number of subjects: 758

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 758
Study: 28078869

Group type: EXPERIMENTAL
Intervention: High energy laser therapy (HELT) at 650 nm
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: High energy laser therapy (HELT) at 810 nm
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: High energy laser therapy (HELT) at TRIAX (simultaneous emission of 810 nm, 980 nm, and 1064 nm)
Number of subjects: 66
Study: 24131862

Group type: EXPERIMENTAL
Intervention: Endoscopic nasobiliary drainage with endoscopic sphincterotomy (EST)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Endoscopic nasobiliary drainage without endoscopic sphincterotomy (non-EST)
Number of subjects: 72
Study: 22234018

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) administered at a dosage of 10 mg/kg before CPB, on CPB, and after CPB
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo administered at the same time intervals as TA
Number of subjects: 80
Study: 20452234

Group type: EXPERIMENTAL
Intervention: Intermittent cold retrograde blood cardioplegia (group B)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Intermittent cold retrograde crystalloid cardioplegia (group C)
Number of subjects: 345
Study: 17707447

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine plus artesunate (SP+AS)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Chloroquine (CQ)
Number of subjects: 190
Study: 15236424

Group type: EXPERIMENTAL
Intervention: Treatment A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment B
Number of subjects: 0
Study: 11437176

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (25 mg/d)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 9516291

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group Skills Training (GST)
Number of subjects: 0
Study: 8041981

Group type: EXPERIMENTAL
Intervention: Epidural meperidine through a PCA pump (initial boluses of 50 mg + infusion of 10 mg/h with additional doses of 25 mg upon patient demand)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.9% saline serum through an epidural PCA system
Number of subjects: 30
Study: 2532099

Group type: EXPERIMENTAL
Intervention: Xiaoke tea
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ordinary tea
Number of subjects: 12
Study: 1211921

Group type: EXPERIMENTAL
Intervention: CP-20,961
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31852485

Group type: EXPERIMENTAL
Intervention: Elos‐Intrauma® nail (Group A)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Gamma 3‐Stryker® nail (Group B)
Number of subjects: 323
Study: 28304313

Group type: EXPERIMENTAL
Intervention: Group music therapy offered once weekly for 16 weeks
Number of subjects: 63

Group type: COMPARATOR
Intervention: Group recreational therapy
Number of subjects: 63
Study: 25887806

Group type: EXPERIMENTAL
Intervention: Triple Antibiotic Paste (TAP) at 1000 mg/mL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Double Antibiotic Paste (DAP) at 1000 mg/mL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Triple Antibiotic Paste (TAP) at 1 mg/mL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Double Antibiotic Paste (DAP) at 1 mg/mL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Triple Antibiotic Paste (TAP) at 0.5 mg/mL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Double Antibiotic Paste (DAP) at 0.5 mg/mL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All concentrations of DAP
Number of subjects: 45

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 45
Study: 24195278

Group type: EXPERIMENTAL
Intervention: Peracetic acid (15 microl/l and 45 microl/l)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chloramine T (2 mg/l)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peracetic acid (45 microl/l)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 22133996

Group type: EXPERIMENTAL
Intervention: IFN/FU + CDDP
Number of subjects: 114

Group type: COMPARATOR
Intervention: IFN/FU
Number of subjects: 114
Study: 19226304

Group type: EXPERIMENTAL
Intervention: Peanut oral immunotherapy (OIT)
Number of subjects: 4
Study: 15894097

Group type: EXPERIMENTAL
Intervention: Anthracycline-based polychemotherapy (e.g., FAC or FEC) for about 6 months
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Tamoxifen for about 5 years
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Ovarian ablation or suppression
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Tamoxifen (5 years) following anthracycline-based chemotherapy
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Anthracycline-based chemotherapy followed by tamoxifen
Number of subjects: 8000
Study: 12165887

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9539602

Group type: EXPERIMENTAL
Intervention: Bupivacaine plus verapamil
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bupivacaine alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bupivacaine plus verapamil (reverse order)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bupivacaine alone (reverse order)
Number of subjects: 100
Study: 7840379

Group type: EXPERIMENTAL
Intervention: 8-mm partial shunts
Number of subjects: 18

Group type: COMPARATOR
Intervention: 16-mm total shunts
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nutrient hepatic blood flow
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nutrient hepatic blood flow > 325 mL/min
Number of subjects: 18
Study: 2195532

Group type: EXPERIMENTAL
Intervention: Polyfrequent oscillation method (reactance, resistance between 2 and 52 Hz)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bodyplethysmography (Raw, FEV1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Transcutaneous oxygen pressure (tc‐PO2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall evaluation of bodyplethysmography and polyfrequent oscillation method
Number of subjects: 30
Study: 623129

Group type: EXPERIMENTAL
Intervention: Carbenicillin, methicillin and gentamicin
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Carbenicillin and cephalothin
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Other antibiotics due to specific indications or counterindications
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Initial responders
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Nonresponders
Number of subjects: 126
Study: 30542782

Group type: EXPERIMENTAL
Intervention: Microfluidic technique (Fertile Chip®)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Conventional swim-up techniques
Number of subjects: 122
Study: 28683212

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/formoterol fumarate (FP/FORM; Flutiform®) pressurized metered-dose inhaler (pMDI)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: FP/FORM K‐haler® (breath-triggered inhaler)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: FP/FORM pMDI
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: FP/FORM K‐haler®
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: K‐haler BTI
Number of subjects: 307
Study: 25631485

Group type: EXPERIMENTAL
Intervention: 3% diquafosol ophthalmic solution
Number of subjects: 497

Group type: COMPARATOR
Intervention: 0.1% sodium hyaluronate ophthalmic solution (HA)
Number of subjects: 497
Study: 23883675

Group type: EXPERIMENTAL
Intervention: Ad libitum high-fiber, low-fat diet and daily exercise (2-2.5 h)
Number of subjects: 33
Study: 21333607

Group type: EXPERIMENTAL
Intervention: PEARLS intervention (home-based collaborative care consisting of problem-solving treatment, behavioral activation, and psychiatric consultation)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study: 19320645

Group type: EXPERIMENTAL
Intervention: Incredible Years Teacher Training programme
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study: 17069905

Group type: EXPERIMENTAL
Intervention: Paclitaxel eluting stents (PES)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 25
Study: 15089811

Group type: EXPERIMENTAL
Intervention: FTY720 (1 mg oral dose) under fasting conditions
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: FTY720 (1 mg oral dose) after a high fat meal
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 11575286

Group type: EXPERIMENTAL
Intervention: Leuprolide and pamidronate (60 mg intravenously every 12 weeks)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Leuprolide alone
Number of subjects: 47
Study: 9490236

Group type: EXPERIMENTAL
Intervention: Probucol (500 mg)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Probucol plus multivitamins
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Multivitamins (beta‐carotene 30000 IU, vitamin C 500 mg, and vitamin E 700 IU)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study: 7945735

Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg of oral yohimbine
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3061885

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg bd
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg at night
Number of subjects: 42
Study: 28856476

Group type: EXPERIMENTAL
Intervention: Ibandronate treatment
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study: 27501966

Group type: EXPERIMENTAL
Intervention: Lipegfilgrastim 6 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25701774

Group type: EXPERIMENTAL
Intervention: DDDRP + MVP
Number of subjects: 768

Group type: COMPARATOR
Intervention: DDDR
Number of subjects: 768
Study: 22930253

Group type: EXPERIMENTAL
Intervention: 6-session structured multidisciplinary intervention
Number of subjects: 131

Group type: COMPARATOR
Intervention: Standard care arm
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: 6-session structured multidisciplinary intervention followed by 10 brief telephone counseling sessions
Number of subjects: 131
Study: 20716738

Group type: EXPERIMENTAL
Intervention: Gentamicin-collagen sponge (2 sponges, total gentamicin of 260 mg)
Number of subjects: 1502

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1502
Study: 18085275

Group type: EXPERIMENTAL
Intervention: LDIH (60-minute daily exposures to normobaric 12% O2)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: SDIH (twelve 5-minute bouts of normobaric 12% O2 separated by 5-minute bouts of room air)
Number of subjects: 10
Study: 15734867

Group type: EXPERIMENTAL
Intervention: Carbenoxolone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11870809

Group type: EXPERIMENTAL
Intervention: Prophylactic use of macrophage colony-stimulating factor (M-CSF) during intensive chemotherapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo during intensive chemotherapies
Number of subjects: 0
Study: 10367219

Group type: COMPARATOR
Intervention: Aspirin (asa) 160 mg/die plus low-intensity oral anticoagulation (target INR: 1.5-2.5)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Picotamide (pico) 300 mg/tid plus low-intensity oral anticoagulation
Number of subjects: 101

Group type: COMPARATOR
Intervention: Cumulative incidence of major clinical events plus major hemorrhagic episodes
Number of subjects: 101
Study: 7563451

Group type: EXPERIMENTAL
Intervention: rt‐PA (alteplase) 1.1 mg/kg
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: rt‐PA (alteplase)
Number of subjects: 620

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 620